The Afuco™ Anti-ACVRL1 ADCC Recombinant Antibody (Ascrinvacumab), ADCC Enhanced from Creative Biolabs is a Human Monoclonal antibody to ACVRL1. This antibody recognizes Human antigen. The Afuco™ Anti-ACVRL1 ADCC Recombinant Antibody (Ascrinvacumab), ADCC Enhanced has been validated for the following applications: EIA, Immunoassay, Precipitation, Block/Neutralize/Inhibit, ELISA, Flow Cytometry, Immunofluorescence, Immunohistochemistry, and Immunoprecipitation.